↓ Skip to main content

Dove Medical Press

Article Metrics

Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
42 Mendeley
Title
<p>Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials</p>
Published in
Neuropsychiatric Disease and Treatment, May 2019
DOI 10.2147/ndt.s198899
Pubmed ID
Authors

Taro Kishi, Ikuo Nomura, Kenji Sakuma, Tsuyoshi Kitajima, Kazuo Mishima, Nakao Iwata

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 14%
Other 5 12%
Student > Bachelor 4 10%
Student > Doctoral Student 3 7%
Professor > Associate Professor 2 5%
Other 7 17%
Unknown 15 36%
Readers by discipline Count As %
Medicine and Dentistry 10 24%
Pharmacology, Toxicology and Pharmaceutical Science 4 10%
Nursing and Health Professions 4 10%
Psychology 2 5%
Immunology and Microbiology 1 2%
Other 5 12%
Unknown 16 38%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2019.
All research outputs
#8,106,323
of 15,377,009 outputs
Outputs from Neuropsychiatric Disease and Treatment
#904
of 2,520 outputs
Outputs of similar age
#113,683
of 266,041 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#3
of 5 outputs
Altmetric has tracked 15,377,009 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,520 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 266,041 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.